Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects

Journal of Nutritional Biochemistry

Volumn 21, Issue 5, 2010, Pages 432-437

  Costarelli, Laura ^a   Muti, Elisa ^a   Malavolta, Marco ^a   Cipriano, Catia ^a   Giacconi, Robertina ^a   Tesei, Silvia ^a   Piacenza, Francesco ^b   Pierpaoli, Sara ^a   Gasparini, Nazzarena ^a   Faloia, Emanuela ^b   Tirabassi, Giacomo ^b   Boscaro, Marco ^b   Polito, Angela ^c   Mauro, Beatrice ^c   Maiani, Francesca ^c   Raguzzini, Anna ^c   Marcellini, Fiorella ^a   Giuli, Cinzia ^a   Papa, Roberta ^a   Emanuelli, Monica ^b   Lattanzio, Fabrizia ^a   Mocchegiani, Eugenio ^a   more..

^a INRCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Array gene expression; Inflammation; Metabolism; Obesity; Zinc

Indexed keywords

ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METALLOTHIONEIN; TRIACYLGLYCEROL; ZINC;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RELEASE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NUCLEOTIDE SEQUENCE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; OXIDATIVE STRESS; PSYCHOLOGIC ASSESSMENT; ZINC BLOOD LEVEL; ZINC METABOLISM;

ADULT; BIOLOGICAL MARKERS; CHOLESTEROL; DIET; FEMALE; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVERWEIGHT; OXIDATIVE STRESS; QUESTIONNAIRES; ZINC;

EID: 77951498199     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.02.001     Document Type: Article

References (59)

1. McManus K., Antinoro L., Sacks F. A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults. Int J Obes Relat Metab Disord 2001, 25:1503-1511.
2. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
3. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
4. Ryan A.S., Nicklas B.J. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004, 27(7):1699-1705.
5. Haffner S.M. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006, 14(Suppl 3):121S-127S.
6. Kumanyika S.K., Obarzanek E., Stettler N., Bell R., Field A.E., Fortmann S.P., et al. Population-based prevention of obesity. The need for comprehensive promotion of healthful eating, physical activity, and energy balance. A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation 2008, 118:428-464.
7. Herbert A. The fat tail of obesity as told by the genome. Curr Opin Clin Nutr Metab Care 2008, 11:366-370.
8. Després J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
9. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Tesei S., et al. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech Ageing Dev 2006, 127:517-525.
10. Chimienti F., Devergnas S., Favier A., Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004, 53:2330-2337.
11. Di Martino G., Matera M.G., De Martino B., Vacca C., Di Martino S., Rossi F. Relationship between zinc and obesity. J Med 1993, 24:177-183.
12. Weisstaub G., Hertrampf E., López de Romaña D., Salazar G., Bugueño C., Castillo-Duran C. Plasma zinc concentration, body composition and physical activity in obese preschool children. Biol Trace Elem Res 2007, 118:167-174.
13. Kennedy M.L., Failla M.L. Zinc metabolism in genetically obese (ob/ob) mice. J Nutr 1987, 117:886-893.
14. Begin-Heick N., Dalpe-Scott M., Rowe J., Heick H.M. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 1985, 34:179-184.
15. Tallman D.L., Taylor C.G. Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in C57BL/6J mice. J Nutr Biochem 2003, 14:17-23.
16. Chen M.D., Lin P.Y., Cheng V., Lin W.H. Zinc supplementation aggravates body fat accumulation in genetically obese mice and dietary-obese mice. Biol Trace Elem Res 1996, 52:125-132.
17. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal 2006, 8:1419-1441.
18. Krezel A., Maret W. Different redox states of metallothionein/thionein in biological tissue. Biochem J 2007, 402:551-558.
19. Ozata M., Mergen M., Oktenli C., Aydin A., Sanisoglu S.Y., Bolu E., et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 2002, 35:627-631.
20. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., et al. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 2002, 37:349-357.
21. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., et al. T-Lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28:1304-1310.
22. Tuthill A., Slawik H., O'Rahilly S., Finer N. Psychiatric co-morbidities in patients attending specialist obesity services in the UK. QJM 2006, 99:317-325.
23. Marcellini F., Giuli C., Papa R., Gagliardi C., Dedoussis G., Monti D., et al. Zinc in elderly people: effects of zinc supplementation on psychological dimensions in dependence of IL-6-174 polymorphism: a Zincage study. Rejuvenation Res 2008, 11:479-483.
24. Commission of the European Communities Nutrient and Energy intakes in the European Community. Reports of the Scientific Committee for Food (Thirty-first series) 1993.
25. Food Composition Tables - Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Ed EDRA 2000.
26. Patel S., Lyons-Weiler J. caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Appl Bioinformatics 2004, 3:49-62.
27. Costarelli L., Muti E., Malavolta M., Giacconi R., Cipriano C., Sartini D., et al. Modulation of genes involved in zinc homeostasis in old low-grade atherosclerotic patients under effects of HMG-CoA reductase inhibitors. Rejuvenation Res 2008, 11:287-291.
28. Malavolta M., Costarelli L., Giacconi R., Muti E., Bernardini G., Tesei S., et al. Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 2006, 69:1043-1053.
29. Misra R.R., Hochadel J.F., Smith G.T., Cook J.C., Waalkes M.P., Wink D.A. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem Res Toxicol 1996, 9:326-332.
30. Saavedra J.E., Shami P.J., Wang L.Y., Davies K.M., Booth M.N., Citro M.L., et al. Esterase sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity. J Med Chem 2000, 43:261-269.
31. Yurkow E.J., Makhijani P.R. Flow cytometric determination of metallothionein levels in human peripheral blood lymphocytes: utility in environmental exposure assessment. J Toxicol Environ Health A 1998, 54:445-457.
32. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., et al. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006, 7:357-365.
33. Malavolta M., Piacenza F., Costarelli L., Giacconi R., Muti E., Cipriano C., et al. Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC. J Analytical Atomic Spectrom 2007, 22:1-6.
34. Derogatis L.R., Cleary P.A. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol 1977, 16:347-356.
35. Gormally J., Black S., Daston S., Rardin D. The assessment of binge eating severity among obese persons. Addict Behav 1982, 7:47-55.
36. Prasad A.S. Zinc and immunity. Mol Cell Biochem 1998, 188:63-69.
37. Maret W., Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 2007, 13:371-375.
38. Smidt K., Pedersen S.B., Brock B., Schmitz O., Fisker S., Bendix J., et al. Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol 2007, 264:68-73.
39. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
40. Andree K.B., Kim J., Kirschke C.P., Gregg J.P., Paik H., Joung H., et al. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J Nutr 2004, 134:1716-1723.
41. Devirgiliis C., Zalewski P.D., Perozzi G., Murgia C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007, 622:84-93.
42. Mantzoros C.S., Prasad A.S., Beck F.W., Grabowski S., Kaplan J., Adair C., et al. Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 1998, 17:270-275.
43. Buchanan C., Mahesh V., Zamorano P., Brann D. Central nervous system effects of leptin. Trends Endocrinol Metab 1998, 9:146-150.
44. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
45. Rawlings N.D., Tolle D.P., Barrett A.J. MEROPS: The peptidase database. Nucleic Acids Res 2004, 32:D160-D164.
46. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 2003, 100:4162-4167.
47. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., et al. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
48. Stienstra R., Duval C., Müller M., Kersten S. PPARs, Obesity, and inflammation. PPAR Res 2007, 2007:95974.
49. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
50. Nayagam V.M., Wang X., Tan Y.C., Poulsen A., Goh K.C., Ng T., et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen 2006, 11:959-967.
51. Herbein G., Varin A., Fulop T. NF-kappaB, AP-1, Zinc-deficiency and aging. Biogerontology 2006, 7(5-6):409-419.
52. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., et al. Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individuals. Rejuvenation Res 2007, 10:603-620.
53. Holbert M.A., Marmorstein R. Structure and activity of enzymes that remove histone modifications. Curr Opin Struct Biol 2005, 15:673-680.
54. Rishi P., Kaur P., Virdi J.S., Shukla G., Koul A. Amelioratory effects of zinc supplementation on Salmonella-induced hepatic damage in the murine model. Dig Dis Sci 2008, 53:1063-1070.
55. Alvarado C., Alvarez P., Puerto M., Gausserès N., Jiménez L., De la Fuente M. Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition 2006, 22:767-777.
56. Kahmann L., Uciechowski P., Warmuth S., Plümäkers B., Gressner A.M., Malavolta M., et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008, 11:227-237.
57. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85:837-844.
58. von Bülow V., Rink L., Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3′,5′-cyclic monophosphate. J Immunol 2005, 175:4697-4705.
59. Aydemir T.B., Blanchard R.K., Cousins R.J. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci U S A 2006, 103:1699-1704.